FDA Inspection 1238030 — BMC 1092, Inc.
The FDA completed an inspection of BMC 1092, Inc. on May 15, 2024 in Broadview, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 15, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Broadview, IL (United States)